These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 26433527

  • 41. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
    Tofukuji S, Ishida S, Katayama K.
    Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Prevalence of sensitization of Japanese cedar pollen in children from infancy to adolescence].
    Masuda S, Fujisawa T, Iguchi K, Atsuta J, Noma Y, Nagao M, Nambu M, Suehiro Y, Kamesaki S, Terada A, Mizuno M, Shimizu S, Tohda Y.
    Arerugi; 2006 Oct; 55(10):1312-20. PubMed ID: 17072111
    [Abstract] [Full Text] [Related]

  • 45. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.
    Murakami D, Kubo K, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Auris Nasus Larynx; 2014 Aug; 41(4):350-8. PubMed ID: 24698163
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
    Yamanaka K, Shah SA, Sakaida H, Yamagiwa A, Masuda S, Mizutani H, Takeuchi K.
    Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K.
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Concentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy--a new mucosal vaccine formulation against Japanese cedar pollen allergy.
    Wakasa Y, Takagi H, Watanabe N, Kitamura N, Fujiwara Y, Ogo Y, Hayashi S, Yang L, Ohta M, Thet Tin WW, Sekikawa K, Takano M, Ozawa K, Hiroi T, Takaiwa F.
    PLoS One; 2015 Jun; 10(3):e0120209. PubMed ID: 25774686
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Molecular cloning and immunochemical characterization of a novel major Japanese cedar pollen allergen belonging to the aspartic protease family.
    Ibrahim AR, Kawamoto S, Aki T, Shimada Y, Rikimaru S, Onishi N, Babiker EE, Oiso I, Hashimoto K, Hayashi T, Ono K.
    Int Arch Allergy Immunol; 2010 Jun; 152(3):207-18. PubMed ID: 20145409
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.